Stardust Solar Retains Investor Relations Services Provider

Vancouver, British Columbia--(Newsfile Corp. - April 22, 2025) - Stardust Solar Energy Inc. (TSXV: SUN) ("Stardust" or the "Company") is pleased to announce that it has retained Dr. Reuter Investor Relations GmbH ("Dr. Reuter) to provide certain investor relations and digital marketing services to the Company. This news release is made in accordance with the requirements of TSX Venture Exchange Policy 3.4 - Investor Relations, Promotional and Market Making Activities.

Dr. Reuter Investor Relations Agreement

Under the terms of the investor relations and public relations agreement dated April 16, 2025 (the "Dr. Reuter Agreement") among the Company and Dr. Reuter, the Company will pay a fixed monthly fee of €4,500 in exchange for certain investor relations and advertising services to be provided in Europe and may engage Dr. Reuter to conduct roadshows for a fee of €4,300 per each day of the applicable roadshow. The Dr. Reuter Agreement will commence on approximately April 16, 2025, and has an initial term of six-months. After the completion of the initial term, the term will extend on a month-to-month basis unless terminated by either party on one months' notice. Dr. Reuter will target the European market by engaging with investors through various digital marketing and social media platforms to increase investor and assist with dissemination of the Company's news.

Dr. Reuter is located in Frankfurt, Germany, has been active in the market since 2006. Dr. Reuter specializes in the European capital markets and offers services in the areas of financial press releases, institutional investor relations and retail investor relations. The principal of Dr. Reuter is Dr. Eva Reuter. To the best of the Company's knowledge Dr. Reuter does not have any equity interest in the securities of the Company, or a right to acquire such an interest. Dr. Reuter and its principal have an arms' length relationship to the Company. The Dr. Reuter Agreement remains subject to the approval of the TSX Venture Exchange. Dr. Reuter may be contacted at the following coordinates: Friedrich Ebert Anlage 35-37, Tower 185, 60327 Frankfurt; Email: [email protected]; Phone: +49-69-1532-5857.

About Stardust Solar

Stardust is a North American franchisor of renewable energy installation services, including solar panels (PV), energy storage systems, and electric vehicle supply equipment. Stardust lends its brand and business management services to entrepreneurs looking to enter the renewable energy industry. Stardust franchisees install and maintain clean energy systems for residential and commercial purposes. As a franchisor, Stardust supplies its franchisees with the following products: solar PV equipment, energy storage equipment, and electric vehicle supply equipment. In addition, Stardust supports its franchisees with many services from corporate headquarters, including marketing, sales, engineering, plan sets, customer service, and project management.

Media and Investor Contacts:

Mark Tadros
Chief Executive Officer, Chairman and Director

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The TSX Venture Exchange Inc. has neither approved nor disapproved the contents of this press release.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements, including statements relating to the Company's business plans and expected future growth, the Dr. Reuter Agreement and the services to be conducted in connection therewith, and the receipt of regulatory approvals. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward‐looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention. It assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/249325